| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Yoshio Yamaoka | Q61084667 |
| P2093 | author name string | Masahiro Asaka | |
| Mototsugu Kato | |||
| P2860 | cites work | Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer | Q24562562 |
| An African origin for the intimate association between humans and Helicobacter pylori | Q24671467 | ||
| Pathogenesis of Helicobacter pylori infection | Q24679810 | ||
| Gain and loss of multiple genes during the evolution of Helicobacter pylori | Q24814896 | ||
| Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin | Q28273716 | ||
| Who ate whom? Adaptive Helicobacter genomic changes that accompanied a host jump from early humans to large felines | Q28768291 | ||
| Altered states: involvement of phosphorylated CagA in the induction of host cellular growth changes by Helicobacter pylori | Q28776428 | ||
| Traces of human migrations in Helicobacter pylori populations | Q29618510 | ||
| Genetic and functional characterization of the alpAB gene locus essential for the adhesion of Helicobacter pylori to human gastric tissue | Q30175791 | ||
| Translocation of the Helicobacter pylori CagA protein in gastric epithelial cells by a type IV secretion apparatus | Q30981200 | ||
| Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites | Q33292319 | ||
| Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection | Q33617838 | ||
| Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases | Q33675894 | ||
| Expanding allelic diversity of Helicobacter pylori vacA. | Q33682538 | ||
| Regulation of IL-18 in Helicobacter pylori infection | Q33683506 | ||
| Polymorphisms of Helicobacter pylori HP0638 reflect geographic origin and correlate with cagA status | Q33946188 | ||
| Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India | Q33994171 | ||
| Allelic Variation within Helicobacter pylori babA and babB | Q34006106 | ||
| Regulation of interleukin-6 promoter activation in gastric epithelial cells infected with Helicobacter pylori | Q34049840 | ||
| Regulation of RANTES promoter activation in gastric epithelial cells infected with Helicobacter pylori | Q34111846 | ||
| Inhibition of primary human T cell proliferation by Helicobacter pylori vacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion | Q34337364 | ||
| Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island | Q34359740 | ||
| Geographic distribution of vacA allelic types of Helicobacter pylori | Q59182779 | ||
| Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori | Q71933876 | ||
| Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach | Q72220074 | ||
| The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany | Q74008989 | ||
| Importance of Helicobacter pylori oipA in clinical presentation, gastric inflammation, and mucosal interleukin 8 production | Q74531603 | ||
| Relationship of vacA genotypes of Helicobacter pylori to cagA status, cytotoxin production, and clinical outcome | Q77650448 | ||
| Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype | Q77900398 | ||
| Correlation between variation of the 3' region of the cagA gene in Helicobacter pylori and disease outcome in Japan | Q78560366 | ||
| Helicobacter pylori infection in mice: Role of outer membrane proteins in colonization and inflammation | Q78582166 | ||
| A new Helicobacter pylori vacuolating cytotoxin determinant, the intermediate region, is associated with gastric cancer | Q81248691 | ||
| East Asian genotypes of Helicobacter pylori strains in Amerindians provide evidence for its ancient human carriage | Q34381395 | ||
| Helicobacter pylori adhesin binding fucosylated histo-blood group antigens revealed by retagging | Q34452414 | ||
| Helicobacter pylori CagA protein can be tyrosine phosphorylated in gastric epithelial cells | Q34507295 | ||
| Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion | Q34507324 | ||
| Helicobacter pylori and atrophic gastritis: importance of the cagA status | Q34718764 | ||
| Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation | Q35015052 | ||
| Functional and intracellular signaling differences associated with the Helicobacter pylori AlpAB adhesin from Western and East Asian strains | Q35087443 | ||
| A Mr 34,000 proinflammatory outer membrane protein (oipA) of Helicobacter pylori | Q35162651 | ||
| Evaluation of the association of nine Helicobacter pylori virulence factors with strains involved in low-grade gastric mucosa-associated lymphoid tissue lymphoma | Q35549290 | ||
| Helicobacter pylori outer membrane proteins and gastroduodenal disease | Q35760550 | ||
| Helicobacter pylori vacuolating cytotoxin, VacA, is responsible for gastric ulceration | Q36020418 | ||
| Helicobacter pylori VacA, a paradigm for toxin multifunctionality | Q36066993 | ||
| Clinical relevance of the Helicobacter pylori gene for blood-group antigen-binding adhesin | Q36556507 | ||
| Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: evidence of linkage to cytotoxin production | Q36780948 | ||
| The pathogenesis of Helicobacter pylori-induced gastro-duodenal diseases | Q37014743 | ||
| cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors | Q37047617 | ||
| Production of a cytotoxin by Helicobacter pylori | Q37404645 | ||
| Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh | Q37414888 | ||
| Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation | Q38351208 | ||
| Natural diversity in the N terminus of the mature vacuolating cytotoxin of Helicobacter pylori determines cytotoxin activity. | Q39499831 | ||
| Helicobacter pylori HopH (OipA) and bacterial pathogenicity: genetic and functional genomic analysis of hopH gene polymorphisms | Q40217600 | ||
| Influence of EPIYA-repeat polymorphism on the phosphorylation-dependent biological activity of Helicobacter pylori CagA. | Q40291840 | ||
| Functional variability of cagA gene in Japanese isolates of Helicobacter pylori | Q40488162 | ||
| Determinants and consequences of different levels of CagA phosphorylation for clinical isolates of Helicobacter pylori. | Q40527352 | ||
| Role of interferon-stimulated responsive element-like element in interleukin-8 promoter in Helicobacter pylori infection | Q40571194 | ||
| Determinants of Non-toxicity in the Gastric Pathogen Helicobacter pylori | Q40648996 | ||
| Distinct diversity of the cag pathogenicity island among Helicobacter pylori strains in Japan | Q40938007 | ||
| Virulence factors of Helicobacter pylori responsible for gastric diseases in Mongolian gerbil | Q41895124 | ||
| Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration | Q42680016 | ||
| Clarifications regarding the 3' repeat region of the cagA gene in Helicobacter pylori and clinical outcome | Q42727625 | ||
| The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. | Q42906330 | ||
| Heterogeneity in the Helicobacter pylori vacA and cagA genes: association with gastroduodenal disease in South Africa? | Q43086792 | ||
| The functional status of the Helicobacter pylori sabB adhesin gene as a putative marker for disease outcome | Q43690184 | ||
| Mice deficient in protein tyrosine phosphatase receptor type Z are resistant to gastric ulcer induction by VacA of Helicobacter pylori | Q44087014 | ||
| Helicobacter pylori and interleukin 1 genotyping: an opportunity to identify high-risk individuals for gastric carcinoma | Q44588813 | ||
| Gastric cancer development in mice lacking the SHP2 binding site on the IL-6 family co-receptor gp130. | Q44709460 | ||
| Helicobacter pylori CagA seropositivity and gastric carcinoma risk in a Japanese American population | Q44746646 | ||
| Development of a mouse model of Helicobacter pylori infection that mimics human disease | Q44933673 | ||
| Helicobacter pylori in North and South America before Columbus. | Q45245199 | ||
| Molecular epidemiology and outcome of Helicobacter pylori infection in Thailand: a cultural cross roads | Q47879837 | ||
| Recombination and clonal groupings within Helicobacter pylori from different geographical regions | Q47965359 | ||
| Purification and characterization of the vacuolating toxin from Helicobacter pylori | Q55040857 | ||
| Molecular epidemiology of Helicobacter pylori: separation of H. pylori from East Asian and non-Asian countries | Q57216315 | ||
| Relationship between the cagA 3' repeat region of Helicobacter pylori, gastric histology, and susceptibility to low pH | Q57216597 | ||
| P433 | issue | 12 | |
| P921 | main subject | Helicobacter pylori | Q180556 |
| Helicobacter pylori infectious disease | Q4497153 | ||
| P304 | page(s) | 1077-1083 | |
| P577 | publication date | 2008-06-16 | |
| P1433 | published in | Internal Medicine | Q6047666 |
| P1476 | title | Geographic differences in gastric cancer incidence can be explained by differences between Helicobacter pylori strains | |
| P478 | volume | 47 |
| Q35953753 | A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems. |
| Q33515285 | A comprehensive sequence and disease correlation analyses for the C-terminal region of CagA protein of Helicobacter pylori. |
| Q39492679 | A global view on cancer incidence and national levels of the human development index. |
| Q40110987 | Antibody reactivity against Helicobacter pylori proteins in a sample of the Spanish adult population in 2008-2013. |
| Q33649947 | Apparent diffusion coefficient by diffusion-weighted magnetic resonance imaging as a sole biomarker for staging and prognosis of gastric cancer |
| Q35314130 | Attenuated CagA oncoprotein in Helicobacter pylori from Amerindians in Peruvian Amazon |
| Q41888843 | Baseline characteristics, survival and direct costs associated to treatment of gastric cancer patients at the National Oncology Institute of Panama from 2012 to 2015: a hospital-based observational study |
| Q37724638 | Characteristics of gastric cancer in Asia |
| Q64120484 | Complete Genome Sequence of Helicobacter pylori Strain GD63, Isolated from a Vietnamese Patient with a Gastric Ulcer |
| Q43483213 | Correlation of Helicobacter pylori genotypes with gastric histopathology in the central region of a South-European country. |
| Q57709938 | Cronkhite-Canada syndrome complicated with huge intramucosal gastric cancer |
| Q37138735 | Current evidence of effects of Helicobacter pylori eradication on prevention of gastric cancer |
| Q34121360 | Decreased expression of SEMA3A is associated with poor prognosis in gastric carcinoma |
| Q34717588 | Differences in interleukin 8 expression in Helicobacter pylori-infected gastric mucosa tissues from patients in Bhutan and the Dominican Republic |
| Q82493503 | Diverse H. pylori strains, IL-10 promoter polymorphisms with high morbidity of gastric cancer in Hexi area of Gansu Province, China |
| Q37451841 | Diverse characteristics of the CagA gene of Helicobacter pylori strains collected from patients from southern vietnam with gastric cancer and peptic ulcer |
| Q37162466 | Diversity of Helicobacter pylori genotypes in Iranian patients with different gastroduodenal disorders |
| Q48063794 | Diversity of the cagA gene of Helicobacter pylori strains from patients with gastroduodenal diseases in the Philippines |
| Q37561771 | EGFR(S) inhibitors in the treatment of gastro-intestinal cancers: what's new? |
| Q37714349 | Effect of treatment failure on the CagA EPIYA motif in Helicobacter pylori strains from Colombian subjects. |
| Q37050708 | Elevated Preoperative Serum Alanine Aminotransferase/Aspartate Aminotransferase (ALT/AST) Ratio Is Associated with Better Prognosis in Patients Undergoing Curative Treatment for Gastric Adenocarcinoma |
| Q37725088 | Epidemiology of Helicobacter pylori infection and gastric cancer in Asia |
| Q24630210 | Evolutionary History of the Helicobacter pylori Genome: Implications for Gastric Carcinogenesis |
| Q58710035 | Exploring Spatial Trends and Influencing Factors for Gastric Cancer Based on Bayesian Statistics: A Case Study of Shanxi, China |
| Q36541982 | Familial gastric cancer: detection of a hereditary cause helps to understand its etiology |
| Q53134388 | Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. |
| Q84276928 | Gastric cancer |
| Q37964084 | Gastric cancer in Africa: what do we know about incidence and risk factors? |
| Q55506767 | Gastric cancer in Alaska Native people: A cancer health disparity. |
| Q33791441 | Gastric cancers of Western European and African patients show different patterns of genomic instability |
| Q37190725 | Genome sequences of 65 Helicobacter pylori strains isolated from asymptomatic individuals and patients with gastric cancer, peptic ulcer disease, or gastritis |
| Q39503239 | Germline alterations in the CDH1 gene in familial gastric cancer in the Japanese population |
| Q37644241 | Glutathione S-transferase T1 (GSTT1) gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiologic studies |
| Q35224562 | Helicobacter pylori from gastric cancer and duodenal ulcer show same phylogeographic origin in the Andean region in Colombia |
| Q33391801 | Helicobacter pylori infection and current clinical areas of contention |
| Q33709984 | Helicobacter pylori infection and gastroduodenal diseases in Vietnam: a cross-sectional, hospital-based study. |
| Q38016313 | Helicobacter pylori infection increases the risk of colorectal adenomas: cross-sectional study and meta-analysis |
| Q37247990 | Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer |
| Q58582563 | Helicobacter pylori outer membrane vesicles involvement in the infection development and Helicobacter pylori-related diseases |
| Q38653511 | Helicobacter pylori screening: options and challenges |
| Q36454540 | Helicobacter pylori strains harboring babA2 from Indian sub population are associated with increased virulence in ex vivo study |
| Q36125580 | Helicobacter pylori virulence genes in the five largest islands of Indonesia |
| Q38954196 | Histone demethylase KDM2A promotes tumor cell growth and migration in gastric cancer |
| Q38971911 | Identification of Helicobacter pylori and the evolution of an efficacious childhood vaccine to protect against gastritis and peptic ulcer disease |
| Q35867858 | Identification of carboxyl terminal peptide of Fibrinogen as a potential serum biomarker for gastric cancer |
| Q55401345 | Identifying the Causes of Cancer Health Disparities: Biologic and Non Biologic Determinants. |
| Q34413936 | In silico evolutionary analysis of Helicobacter pylori outer membrane phospholipase A (OMPLA) |
| Q58559799 | Introduction of endoscopic submucosal dissection in the West |
| Q40601723 | Isolation and characterization of Helicobacter pylori recovered from gastric biopsies under anaerobic conditions |
| Q48156222 | Letter: the risk of cancer in patients with gastric intestinal metaplasia. |
| Q98735735 | Long Non-coding RNA FGD5-AS1 Regulates Cancer Cell Proliferation and Chemoresistance in Gastric Cancer Through miR-153-3p/CITED2 Axis |
| Q39407479 | MicroRNA-223 functions as an oncogene in human gastric cancer by targeting FBXW7/hCdc4. |
| Q34091160 | Mixed infection with cagA positive and cagA negative strains of Helicobacter pylori lowers disease burden in The Gambia |
| Q35726552 | Molecular Epidemiology of Helicobacter pylori Infection in Nepal: Specific Ancestor Root |
| Q50100052 | Nodular gastritis. |
| Q38423185 | Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis |
| Q55084846 | Prevalence of Helicobacter pylori and its CagA subtypes in gastric cancer and duodenal ulcer at an Austrian tertiary referral center over 25 years. |
| Q41867817 | Prevalence of Helicobacter pylori vacA different genotypes in Isfahan, Iran |
| Q30252088 | Prevalence of Primary Antimicrobial Resistance of H. pylori in Turkey: A Systematic Review |
| Q37122179 | Prevalence of vacA, cagA and babA2 genes in Cuban Helicobacter pylori isolates |
| Q52886448 | Prognostic relevance of gastric cancer staging by endoscopic ultrasound. |
| Q26853203 | Racial differences in eosinophilic gastrointestinal disorders among Caucasian and Asian |
| Q38858802 | Rare Variants in the Epithelial Cadherin Gene Underlying the Genetic Etiology of Nonsyndromic Cleft Lip with or without Cleft Palate |
| Q38029324 | Recent Insights into Antibiotic Resistance in Helicobacter pylori Eradication |
| Q38518256 | Recognition of and recent issues in hereditary diffuse gastric cancer |
| Q26746251 | Relationship between vacA Types and Development of Gastroduodenal Diseases |
| Q53665182 | Retrospective evaluation of the efficacy of first-line treatment of advanced gastric cancer with docetaxel and oxaliplatin. |
| Q26778023 | Role of Helicobacter pylori infection in gastric carcinogenesis: Current knowledge and future directions |
| Q37732285 | Role of capecitabine and irinotecan combination therapy in advanced or metastatic gastric cancer |
| Q39543042 | Should we still subcategorize helicobacter pylori-associated dyspepsia as functional disease? |
| Q39370122 | Snail is an independent prognostic predictor for progression and patient survival of gastric cancer |
| Q39015708 | Spindle and kinetochore-associated protein 1 is overexpressed in gastric cancer and modulates cell growth |
| Q34745926 | Survival of non-Western first generations immigrants with stomach cancer in North East Netherlands |
| Q44622362 | Survival of stomach and esophagus cancer patients in Germany in the early 21st century |
| Q97645817 | Syzygium aromaticum L.: Traditional herbal medicine against cagA and vacA toxin genes-producing drug resistant Helicobacter pylori |
| Q41151285 | The Prevalence of Helicobacter pylori Virulence Factors in Bhutan, Vietnam, and Myanmar Is Related to Gastric Cancer Incidence. |
| Q82910676 | The cag PAI is intact and functional but HP0521 varies significantly in Helicobacter pylori isolates from Malaysia and Singapore |
| Q35794384 | The clearance effect of bovine anti-Helicobacter pylori antibody-containing milk in O blood group Helicobacter pylori-infected patients: a randomized double-blind clinical trial |
| Q38238745 | Treatment of Helicobacter pylori infection: meeting the challenge of antimicrobial resistance |
| Q35688584 | Treatment of resectable gastric cancer |
| Q34643128 | Trends and results in treatment of gastric cancer over last two decades at single East European centre: a cohort study |
| Q42317061 | Tumor Size Is a Critical Factor in Adjuvant Chemotherapy for T3-4aN0M0 Gastric Cancer Patients after D2 Gastrectomy |
| Q34277478 | Using stool antigen to screen for Helicobacter pylori in immigrants and refugees from high prevalence countries is relatively cost effective in reducing the burden of gastric cancer and peptic ulceration |
| Q37591512 | Vaccinating against Helicobacter pylori in the developing world. |
| Q35858125 | c-Src and c-Abl kinases control hierarchic phosphorylation and function of the CagA effector protein in Western and East Asian Helicobacter pylori strains |
Search more.